Neurawell Therapeutics, Inc.
Sunny Isles Beach, US · Delaware corporation · 1 known investors
Founders & leadership
MA
Magid AbrahamNamed on SEC filing
TI
Tom InselNamed on SEC filing
Board
JA
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2024
▶$1.6MraisedJun 2024 · 4 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJun 2024 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jack AbrahamDirector
- Magid AbrahamExecutive Officer, Director
- Tom InselExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.6M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Neurawell Therapeutics, Inc.'s investors?
- Neurawell Therapeutics, Inc.'s investors include Atomic.
- How much funding has Neurawell Therapeutics, Inc. raised?
- Neurawell Therapeutics, Inc. has disclosed $1.6M raised across 1 round.
- Where is Neurawell Therapeutics, Inc. headquartered?
- Neurawell Therapeutics, Inc. is headquartered in Sunny Isles Beach, US.